urokinase plasminogen activator (University of Colorado)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameurokinase plasminogen activator (University of Colorado)
Drug Alias Nameurokinase plasminogen activator inhibiting antibodies (University of Colorado)
ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUrokinase plasminogen activator inhibitors
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjurySepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Colorado SystemUniversity Of Colorado
Active IndicationsN/A
Inactive IndicationsRespiratory Distress Syndrome, AdultAcute Lung InjurySepsis

Other Information

ATC CodeN/A
Related LinksN/A